Stock Titan Analysis
What Changed
Price Move History
- Daily moves over 5%
- 7 252 sessions, October 23, 2025 to October 23, 2026
- Largest daily move
- -14.3% close of January 27, 2026
- 1-year change
- +27.1% closing prices, October 23, 2025 to October 23, 2026
- 1-month change
- +10.4% closing prices, September 23, 2026 to October 23, 2026
Company Description
Elevance Health, Inc. (NYSE: ELV) is a health benefits company in the direct health and medical insurance carriers industry within the broader finance and insurance sector. According to its public communications, Elevance Health describes itself as a lifetime, trusted health partner whose purpose is to improve the health of humanity. The company states that it supports consumers, families, and communities across the entire healthcare journey by connecting them to care, support, and resources that help them lead better lives.
Elevance Health’s companies serve approximately over 109 million consumers, as referenced in multiple Business Wire releases, through a portfolio of medical, pharmacy, behavioral, clinical, home health, and complex care solutions. The company’s operations include health plans and related services that span employer-sponsored coverage, individual coverage, and government-sponsored programs such as Medicare Advantage and Medicaid, as reflected in its earnings release and membership metrics.
Business model and segments
Elevance Health’s financial disclosures describe two primary reportable segments: Health Benefits and Carelon. The Health Benefits segment includes Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid, and Federal Employee Program businesses. This segment focuses on providing medical benefits and related services to a broad base of commercial, Medicare, Medicaid, and federal employee members, as shown in the company’s membership tables and segment highlights.
The Carelon segment, which is comprised of CarelonRx and Carelon Services, focuses on pharmacy and other healthcare services. In its third quarter 2025 earnings release, Elevance Health notes that Carelon includes pharmacy benefit management activities, product revenue from CarelonRx, and services such as complex and home care management and behavioral health administration through Carelon Services. The company has highlighted growth in CarelonRx product revenue and the scaling of Carelon Services risk-based solutions.
Role in Blue Cross Blue Shield system and health plan offerings
Polygon data and rating agency commentary indicate that Elevance Health operates as a major health insurer in the United States and serves as the licensee for Blue Cross Blue Shield branded coverage in 14 states. AM Best’s rating discussion refers to these operations collectively as Anthem Health and notes that Elevance operates Blue Cross Blue Shield plans in those states, alongside non-Blue-branded entities such as Wellpoint. Elevance’s Health Benefits segment includes BlueCard membership and a broad range of commercial and government lines of business.
Elevance Health’s public statements emphasize that its affiliated health plans support members through employer-sponsored insurance, individual plans, and government-sponsored programs. The company highlights the evolution of health plans from primarily administrative functions toward a broader role that includes preventive care support, chronic disease management, and integration of behavioral health. Its communications describe health plans that aim to simplify the healthcare experience, personalize care, and work with community organizations to improve health outcomes.
Whole-health and community-focused approach
In its news releases, Elevance Health frequently describes a whole-health approach, which considers physical, behavioral, and social factors together. The company notes that decades of data demonstrate the importance of addressing behavioral health and social drivers of health, not just physical metrics. Examples cited include expanded access to doula care for pregnant members and benefits within certain Medicare Advantage and Medicaid plans that may support individual health and social needs with funds for nutritious food, over-the-counter medications, and transportation services.
Elevance Health also highlights community partnerships as part of its approach. One release describes collaboration with schools and local markets to improve access to nutritious food, and another details support for a middle school weight room renovation in Indianapolis as part of its commitment to whole health in communities. The company points to volunteer hours and supported events, such as community gardens and fitness facilities, as ways it works with local organizations to promote health where people live, learn, and play.
Digital tools, personalization, and member experience
Elevance Health’s communications describe a focus on making healthcare more intuitive and personalized. The company references AI-enabled digital solutions and data-driven insights that are intended to simplify access to care and improve outcomes. One example is the Virtual Assistant, a digital experience available through the Sydney Health app and Elevance Health–affiliated health plan websites. According to the company, this tool uses conversational technology to help members understand their benefits, compare costs, locate in-network providers, check claims, and pay bills. The Virtual Assistant also supports Spanish translation and integrates with the company’s Find Care platform.
The company further describes care managers and concierge-style programs that support members with serious illnesses and complex needs. In its public commentary, Elevance Health notes that its care managers can help with tasks such as finding specialists, addressing housing-related concerns, and providing regular check-ins. It also references a “My Health Advocate” model in certain Medicare plans, where a care manager (advocate) builds an ongoing relationship with a member to help coordinate care and resolve issues.
Government programs and Food as Medicine initiatives
Elevance Health participates in government-sponsored programs, including Medicare Advantage and Medicaid, as indicated by its segment reporting and membership data. The company’s communications describe efforts to integrate social and nutritional support into care for Medicaid members and others at risk for diet-related chronic conditions. Through its Nourished Well program and a partnership with the National Association of Community Health Centers, Elevance Health is working to integrate Food as Medicine programming into primary care at community health centers.
According to the company and NACHC, this initiative trains primary care provider teams to screen and enroll eligible Medicaid members into evidence-based nutrition and dietary services. The partnership supports a Food as Medicine ecosystem that includes food access and security, clinical integration of nutrition protocols, and lifestyle interventions delivered by dietitians and community resources. Elevance Health Foundation, the company’s philanthropic arm, is also supporting NACHC through a Food as Medicine grant to assess existing programs and develop scalable models.
Financial profile and credit ratings context
Elevance Health regularly reports its financial results and capital structure through SEC filings and earnings releases. For the quarter ended September 30, 2025, the company reported operating revenue and segment results for Health Benefits and Carelon, along with membership metrics across commercial, Medicare, Medicaid, and Federal Employee Program lines. Its disclosures discuss benefit expense ratios, operating expense ratios, cash flows, and capital deployment, including share repurchases and dividends.
AM Best’s rating actions on Elevance Health and its subsidiaries provide additional context on the company’s financial strength. AM Best affirmed or upgraded the Financial Strength Ratings and Long-Term Issuer Credit Ratings of various Elevance-affiliated entities, including Blue Cross Blue Shield-branded subsidiaries, Wellpoint entities, and Granular Insurance Company. The rating agency cites factors such as very strong risk-adjusted capitalization, favorable operating performance, diversified product offerings, and enterprise risk management practices. AM Best also notes Elevance’s access to credit facilities, commercial paper programs, and Federal Home Loan Bank borrowings.
Corporate governance and capital markets activity
Elevance Health’s SEC filings document ongoing governance and capital markets activity. In 8-K filings, the company reports the election of independent directors to its board and their committee assignments, including appointments to the Audit and Finance Committees. These filings also confirm that such directors qualify as audit committee financial experts under SEC regulations and are compensated under the company’s standard non-employee director program.
In another 8-K, Elevance Health describes a notes offering in which it issued multiple tranches of senior notes with maturities extending to 2055. The company states that it intends to use the net proceeds to repay or redeem certain existing senior notes and for working capital and general corporate purposes, which may include funding acquisitions, repaying other debt, and repurchasing common stock under its share repurchase program.
Investor communications and guidance
Elevance Health uses press releases and 8-K filings to communicate with investors about earnings results and expectations. The company issues detailed earnings releases for its quarterly results and hosts conference calls and webcasts to review performance and outlook. In certain 8-K filings under Regulation FD, Elevance Health notes that officers plan to speak with investors and reaffirm earnings and benefit expense ratio guidance for the year, while emphasizing that such expectations are forward-looking and subject to risks and uncertainties.
Stock Performance
Elevance Health (ELV) closed at $439.95 on October 23, 2026. Over the past 12 months, the price has gained 27.1%.
ELV Metrics & Rankings
Price returns through October 23, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Elevance Health has 10 recent news articles, with the latest published 4 days ago. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, conferences, earnings date, partnership. View all ELV news →
SEC Filings
Elevance Health has filed 10 recent SEC filings, including 6 Form 4, 2 Form 8-K, 1 Form 144, 1 Form 10-Q. The most recent filing was submitted on October 23, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ELV SEC filings →
Insider Radar
Insider selling at Elevance Health over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.
Financial Highlights
Elevance Health generated $199.1B in revenue in FY2025, operating income reached $7.2B (3.6% operating margin), and net income was $5.7B, reflecting a 2.8% net profit margin. Diluted earnings per share stood at $25.21. The company generated $4.3B in operating cash flow. The current ratio was 1.54, measuring current assets divided by current liabilities.
Upcoming Events
Carelon president start
Special advisor term end
Medicare plan coverage start
Elevance Health has 3 upcoming scheduled events. The next event, "Carelon president start", is scheduled for December 1, 2026 (in 37 days). Investors can track these dates to stay informed about potential catalysts that may affect the ELV stock price.
Short Interest History
Short interest in Elevance Health (ELV) currently stands at 4.9 million shares, down 9.0% from the previous reporting period, representing 2.3% of the float. Since October 2025, short interest has increased by 39.5%.
Days to Cover History
Days to cover for Elevance Health (ELV) currently stands at 3.9 days, down 6.9% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has increased by 115.4%. Across the settlements charted above, it has ranged from 1.2 to 6.6 days.
ELV Company Profile & Sector Positioning
Elevance Health (ELV) operates in the Healthcare Plans industry within the broader Healthcare sector and is listed on the NYSE. Among dividend-paying stocks, ELV ranks #1,507 by dividend yield.
Investors comparing ELV often look at related companies in the same sector, including The Cigna Group (CI), CVS Health Corporation (CVS), Humana Inc. (HUM), Centene Corporation (CNC), and Molina Healthcare, Inc. (MOH). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ELV's relative position within its industry.